DACT1 expression has been shown to be significantly downregulated in hepatocellular carcinoma (HCC) [13], gastrointestinal stromal tumors [14], non-small cell lung cancer (NSCLC) [15] and breast cancer [16]. Here, DACT1 is linked to non-small cell lung carcinoma.